Does expanding social protection schemes substantially increase informality? Whether there is such a trade-off is a key question for policymakers wanting to protect workers and their families from economic and health shocks but concerned not to generate negative side-effects. The case for social protection is clear. There are global commitments such as the … [Read more...] about Does health insurance for the informal sector have an impact on formal employment?
Health Spending and Financing
Can We Do Better than Normal for Health?
In the third year of the COVID-19 pandemic it is easy to both remain stunned by the pandemic’s impact and long for some kind of normalcy. That is certainly true for health systems in Latin America and the Caribbean, which were hit hard and are struggling to recover. But what should recovery look like? While it is tempting to be nostalgic about pre-pandemic times, those were … [Read more...] about Can We Do Better than Normal for Health?
Can We Afford a Healthy Future?
In the early 1960s, when United States healthcare expenses reached 3% of GDP, members of the U.S. Congress were so outraged that they held hearings to address such an unsustainable level of spending. The passing years have shown that 3% was not only sustainable, it was cheap. Today, healthcare spending in the United States is over 17% of GDP. The countries of … [Read more...] about Can We Afford a Healthy Future?
The hidden beauty of costing health
A major policy focus in moving toward UHC (Universal Health Coverage) has been on the key policy question: what services should be made available and under what conditions? And health benefits packages (HBPs) are an answer to this question as they refer to explicitly defined services that can be feasibly financed and provided under the actual circumstances in which a given … [Read more...] about The hidden beauty of costing health
3 reasons why countries should purchase COVID-19 Vaccines at Risk
The COVID-19 pandemic is disrupting lives and economies. The World Bank estimates global GDP losses of US$12 trillion over 2020-2021, implying a US$500 million benefit to ending the pandemic just one month sooner. In this context, we need access to a safe and effective vaccine on a faster schedule than ever before achieved for a new disease. This will require significant … [Read more...] about 3 reasons why countries should purchase COVID-19 Vaccines at Risk